

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma announced new data on its lead drug, exeporfinium chloride (XF-73), on Monday.


(Alliance News) - Destiny Pharma PLC on Monday announced positive data for its lead drug exeporfinium chloride, known as XF-73, and to be presented in...


(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday.


(Alliance News) - Destiny Pharma PLC on Monday proposed going private to pursue funding opportunities after failing to secure a licensing partner.


Destiny Pharma PLC - biotechnology company, focused on developing and commercialising medicines for life-threatening infections - Announces new data o...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...